Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?

For years, upfront autologous hematopoietic cell transplant (auto-HCT) has been the standard of care for younger and physically fit mantle cell lymphoma (MCL) patients after chemoimmunotherapy (CIT) induction. Bruton’s tyrosine kinase (BTK) inhibitors have proven to be excellent salvage therapies, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Beitinjaneh, Amer, Kaufman, Adrienne, Wang, Yucai, Jain, Preetesh, Srour, Samer A, Wang, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Lymphoma (JL Muñoz, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557996/
https://www.ncbi.nlm.nih.gov/pubmed/36227407
http://dx.doi.org/10.1007/s11864-022-01020-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557996/
https://www.ncbi.nlm.nih.gov/pubmed/36227407
http://dx.doi.org/10.1007/s11864-022-01020-9

Ejemplares similares